{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:17:05Z","timestamp":1783408625045,"version":"3.54.6"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Colour vision changes are a key clinical feature of many acquired retinal and optic nerve disorders. Current clinical tests are often labour-intensive or designed for congenital defects. We introduce the novel LSS-8 test, which measures colour saturation thresholds across eight hues. Three cohorts with mixed ocular health underwent testing in a diagnostic crossover study. The reliability cohort was tested with LSS-4 on different days (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930 eyes). The screen independence cohort used LSS-8 with 11-inch versus 13-inch screens in random order (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200927 eyes). Brightness independence testing used LSS-8 at 115\u2009cd\/m\n                    <jats:sup>2<\/jats:sup>\n                    versus 230\u2009cd\/m\n                    <jats:sup>2<\/jats:sup>\n                    (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200919 eyes). Scores for each plate set and total scores were recorded. Intraclass correlation coefficients (ICC) and difference frequency distributions were calculated. Data from 74 eyes (74 subjects; mean age 62.4 \u00b1 19.1 years; range 20\u201385; 39% female) were analysed, with two participants contributing to two study phases. LSS-4 test-retest reliability with ICC(2,1) was good to excellent (mauve 0.93, red 0.95, green 0.87, blue 0.91, total score 0.96). LSS-8 screen independence testing showed excellent reliability for mauve, green, pink and total scores, and moderate to good reliability for other hues (ICC(2,k) 0.74\u20130.98). Varying screen brightness did not produce significant score differences in most participants. The LSS is a simple, reliable test with potential for rapid quantification of acquired colour vision defects.\n                  <\/jats:p>","DOI":"10.1186\/s12886-026-04907-5","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:46:47Z","timestamp":1780292807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a novel and graded colour saturation threshold test, the LSS-8"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1858-4250","authenticated-orcid":false,"given":"Kristyna","family":"Stepnicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sarossy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sarossy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"3","key":"4907_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/13816810490498341","volume":"25","author":"A Melamud","year":"2004","unstructured":"Melamud A, Hagstrom S, Traboulsi E. Color vision testing. Ophthalmic Genet. 2004;25(3):159\u201387. https:\/\/doi.org\/10.1080\/13816810490498341.","journal-title":"Ophthalmic Genet"},{"key":"4907_CR2","first-page":"131","volume-title":"Handb Clin Neurol. 178","author":"J Carroll","year":"2021","unstructured":"Carroll J, Conway BR. Color vision. In: Barton JJS, Leff A, editors. Handb Clin Neurol. 178. Elsevier; 2021. p. 131\u201353."},{"issue":"3","key":"4907_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1444-0938.2007.00135.x","volume":"90","author":"BL Cole","year":"2007","unstructured":"Cole BL. Assessment of inherited colour vision defects in clinical practice. Clin Exp Optometry. 2007;90(3):157\u201375. https:\/\/doi.org\/10.1111\/j.1444-0938.2007.00135.x.","journal-title":"Clin Exp Optometry"},{"key":"4907_CR4","first-page":"269","volume-title":"Human color vision","author":"C Huchzermeyer","year":"2016","unstructured":"Huchzermeyer C, Kremers J, Barbur J. Color vision in clinical practice. In: Kremers J, Baraas RC, Marshall NJ, editors. Human color vision. Cham: Springer International Publishing; 2016. p. 269\u2013315."},{"issue":"5","key":"4907_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/eye.2009.251","volume":"24","author":"MP Simunovic","year":"2010","unstructured":"Simunovic MP. Colour vision deficiency. Eye. 2010;24(5):747\u201355. https:\/\/doi.org\/10.1038\/eye.2009.251.","journal-title":"Eye"},{"issue":"2","key":"4907_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.survophthal.2015.11.004","volume":"61","author":"MP Simunovic","year":"2016","unstructured":"Simunovic MP. Acquired color vision deficiency. Surv Ophthalmol. 2016;61(2):132\u201355. https:\/\/doi.org\/10.1016\/j.survophthal.2015.11.004.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"4907_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","volume":"13","author":"AT Toosy","year":"2014","unstructured":"Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83\u201399. https:\/\/doi.org\/10.1016\/S1474-4422(13)70259-X.","journal-title":"The Lancet Neurol"},{"issue":"2\u20133","key":"4907_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/21678707.2020.1735352","volume":"8","author":"M Menghini","year":"2020","unstructured":"Menghini M, Cehajic-Kapetanovic J, MacLaren RE. Monitoring progression of retinitis pigmentosa: current recommendations and recent advances. Expert Opin Orphan Drugs. 2020;8(2\u20133):67\u201378. https:\/\/doi.org\/10.1080\/21678707.2020.1735352.","journal-title":"Expert Opin Orphan Drugs"},{"issue":"3","key":"4907_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10792-019-01218-1","volume":"40","author":"L Bayer","year":"2020","unstructured":"Bayer L, Funk J, Toteberg-Harms M. Incidence of dyschromatopsy in glaucoma. Int Ophthalmol. 2020;40(3):597\u2013605. https:\/\/doi.org\/10.1007\/s10792-019-01218-1.","journal-title":"Int Ophthalmol"},{"key":"4907_CR10","doi-asserted-by":"publisher","unstructured":"Vemala R, Sivaprasad S, Barbur JL. Detection of early loss of color vision in age-related macular degeneration \u2013 with emphasis on drusen and Reticular Pseudodrusen. Invest Ophthalmol Vis Sci 2017;58(6):BIO247\u201354. https:\/\/doi.org\/10.1167\/iovs.17-21771.","DOI":"10.1167\/iovs.17-21771"},{"issue":"2","key":"4907_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10633-014-9476-4","volume":"130","author":"BE Wolff","year":"2015","unstructured":"Wolff BE, Bearse MA, Schneck ME, Dhamdhere K, Harrison WW, Barez S, et al. Color vision and neuroretinal function in diabetes. Doc Ophthalmol. 2015;130(2):131\u201339. https:\/\/doi.org\/10.1007\/s10633-014-9476-4.","journal-title":"Doc Ophthalmol"},{"issue":"12","key":"4907_CR12","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1038\/s41433-024-03140-y","volume":"38","author":"L Bonelli","year":"2024","unstructured":"Bonelli L, Menon V, Arnold AC, Mollan SP. Managing idiopathic intracranial hypertension in the eye clinic. Eye. 2024;38(12):2472\u201381. https:\/\/doi.org\/10.1038\/s41433-024-03140-y.","journal-title":"Eye"},{"key":"4907_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cortex.2022.12.001","volume":"159","author":"AH Munk","year":"2023","unstructured":"Munk AH, Starup EB, Lambon Ralph MA, Leff AP, Starrfelt R, Robotham RJ. Colour perception deficits after posterior stroke: not so rare after all? Cortex. 2023;159:118\u201330. https:\/\/doi.org\/10.1016\/j.cortex.2022.12.001.","journal-title":"Cortex"},{"key":"4907_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cortex.2020.06.006","volume":"134","author":"K Spang","year":"2021","unstructured":"Spang K, Grimsen C, Prass M, Brunner F, Kohnlein M, Kehrer S, et al. Midlevel visual deficits after strokes involving area human V4. Cortex. 2021;134:207\u201322. https:\/\/doi.org\/10.1016\/j.cortex.2020.06.006.","journal-title":"Cortex"},{"issue":"9","key":"4907_CR15","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.3390\/ijms23094883","volume":"23","author":"W Liu","year":"2022","unstructured":"Liu W, Liu S, Li P, Yao K. Retinitis pigmentosa: progress in molecular pathology and biotherapeutical strategies. Int J Mol Sci. 2022;23(9):4883. https:\/\/doi.org\/10.3390\/ijms23094883.","journal-title":"IJMS"},{"issue":"4","key":"4907_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","volume":"17","author":"DA Antonetti","year":"2021","unstructured":"Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17(4):195\u2013206. https:\/\/doi.org\/10.1038\/s41574-020-00451-4.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"4907_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/ceo.12724","volume":"44","author":"DS Ng","year":"2016","unstructured":"Ng DS, Chiang PP, Tan G, Cheung CG, Cheng C-Y, Cheung CY, et al. Retinal ganglion cell neuronal damage in diabetes and diabetic retinopathy. Clin Exp Ophthalmol. 2016;44(4):243\u201350. https:\/\/doi.org\/10.1111\/ceo.12724.","journal-title":"Clin Exper Ophthalmol"},{"issue":"13","key":"4907_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3238\/arztebl.2020.0225","volume":"117","author":"AK Schuster","year":"2020","unstructured":"Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N. The diagnosis and treatment of glaucoma. Dtsch Arztebl Int. 2020;117(13):225\u201334. https:\/\/doi.org\/10.3238\/arztebl.2020.0225.","journal-title":"Deutsches \u00c4rzteblatt Int"},{"issue":"1","key":"4907_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41433-024-03408-3","volume":"39","author":"W Bouthour","year":"2025","unstructured":"Bouthour W, Bruce BB, Newman NJ, Biousse V. Factors associated with vision loss in idiopathic intracranial hypertension patients with severe papilledema. Eye. 2025;39(1):185\u201391. https:\/\/doi.org\/10.1038\/s41433-024-03408-3.","journal-title":"Eye"},{"issue":"12","key":"4907_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","volume":"14","author":"A Jorge","year":"2018","unstructured":"Jorge A, Ung C, Young LH, Melles RB, Choi HK. Hydroxychloroquine retinopathy \u2014 implications of research advances for rheumatology care. Nat Rev Rheumatol. 2018;14(12):693\u2013703. https:\/\/doi.org\/10.1038\/s41584-018-0111-8.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"4907_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/ICU.0000000000000416","volume":"28","author":"PD Chamberlain","year":"2017","unstructured":"Chamberlain PD, Sadaka A, Berry S, Lee AG. Ethambutol optic neuropathy. Curr Opin Ophthalmol. 2017;28(6):545\u201351. https:\/\/doi.org\/10.1097\/ICU.0000000000000416.","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"4907_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41433-023-02643-4","volume":"38","author":"S MacVinish","year":"2024","unstructured":"MacVinish S, McMaster D, Moledina T, Tamne SK, Ashworth J, Anderson SR. Ethambutol and visual assessment in England: current practice and recommendations. Eye. 2024;38(1):112\u201317. https:\/\/doi.org\/10.1038\/s41433-023-02643-4.","journal-title":"Eye"},{"issue":"2","key":"4907_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/APO.0000000000000605","volume":"12","author":"S Somisetty","year":"2023","unstructured":"Somisetty S, Santina A, Sarraf D, Mieler WF. The impact of systemic medications on retinal function. Asia Pac J Ophthalmol (Phila). 2023;12(2):115\u201357. https:\/\/doi.org\/10.1097\/APO.0000000000000605.","journal-title":"Asia-Pac J Ophthalmol"},{"issue":"10","key":"4907_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.7326\/0003-4819-116-10-876_2","volume":"116","author":"DJ Forster","year":"1992","unstructured":"Forster DJ, Causey DM, Rao NA. Bull\u2019s eye retinopathy and Clofazimine. Ann Intern Med. 1992;116(10):876\u201377. https:\/\/doi.org\/10.7326\/0003-4819-116-10-876_2.","journal-title":"Ann Intern Med"},{"issue":"5","key":"4907_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00415-025-13080-6","volume":"272","author":"J Lin","year":"2025","unstructured":"Lin J, Finkelstein DI, Anderson AJ, Lee PY, Bui BV, Wijeratne T, et al. Keeping an eye on Parkinson\u2019s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers. J Neurol. 2025;272(5):351. https:\/\/doi.org\/10.1007\/s00415-025-13080-6.","journal-title":"J Neurol"},{"issue":"1","key":"4907_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(22)00187-9","volume":"22","author":"JL Bennett","year":"2023","unstructured":"Bennett JL, Costello F, Chen JJ, Petzold A, Biousse V, Newman NJ, et al. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment. Lancet Neurol. 2023;22(1):89\u2013100. https:\/\/doi.org\/10.1016\/S1474-4422(22)00187-9.","journal-title":"The Lancet Neurol"},{"issue":"8","key":"4907_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrneurol.2014.108","volume":"10","author":"A Petzold","year":"2014","unstructured":"Petzold A, Wattjes MP, Costello F, Flores-Rivera J, Fraser CL, Fujihara K, et al. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014;10(8):447\u201358. https:\/\/doi.org\/10.1038\/nrneurol.2014.108.","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"4907_CR28","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","volume":"21","author":"A Petzold","year":"2022","unstructured":"Petzold A, Fraser CL, Abegg M, Alroughani R, Alshowaeir D, Alvarenga R, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022;21(12):1120\u201334. https:\/\/doi.org\/10.1016\/S1474-4422(22)00200-9.","journal-title":"The Lancet Neurol"},{"issue":"4","key":"4907_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7869\/djo.653","volume":"31","author":"R Aggarwal","year":"2021","unstructured":"Aggarwal R, Sethi P, Duvesh RK, Sethi HS, Naik M, Rai HK. Ocular toxicity of anti-tubercular drugs. Delhi J Ophthalmol. 2021;31(4):35\u201338. https:\/\/doi.org\/10.7869\/djo.653.","journal-title":"Delhi J Ophthalmol"},{"issue":"5","key":"4907_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/aos.12515","volume":"93","author":"A Grzybowski","year":"2015","unstructured":"Grzybowski A, Zulsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015;93(5):402\u201310. https:\/\/doi.org\/10.1111\/aos.12515.","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"4907_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/medsci14010003","volume":"14","author":"E Oktaviani","year":"2025","unstructured":"Oktaviani E, Anggadiredja K, Amalia L. Adverse drug reaction to linezolid in drug-resistant tuberculosis: a systematic review. Med Sci. 2025;14(1):3. https:\/\/doi.org\/10.3390\/medsci14010003.","journal-title":"Med Sci"},{"issue":"5","key":"4907_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1475-1313.1997.tb00072.x","volume":"17","author":"J Birch","year":"1997","unstructured":"Birch J. Efficiency of the Ishihara test for identifying red-green colour deficiency. Ophthalmic Physiol Opt. 1997;17(5):403\u201308. https:\/\/doi.org\/10.1111\/j.1475-1313.1997.tb00072.x.","journal-title":"Oph Phys Optics"},{"issue":"10","key":"4907_CR33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1364\/JOSA.33.000568","volume":"33","author":"D Farnsworth","year":"1943","unstructured":"Farnsworth D. The Farnsworth-Munsell 100-hue and dichotomous tests for color vision. J Opt Soc Am. 1943;33(10):568\u201378. https:\/\/doi.org\/10.1364\/JOSA.33.000568.","journal-title":"J Opt Soc Am"},{"issue":"4\u20135","key":"4907_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1444-0938.2004.tb05057.x","volume":"87","author":"SJ Dain","year":"2004","unstructured":"Dain SJ. Clinical colour vision tests. Clin Exp Optometry. 2004;87(4\u20135):276\u201393. https:\/\/doi.org\/10.1111\/j.1444-0938.2004.tb05057.x.","journal-title":"Clin Exp Optometry"},{"issue":"7","key":"4907_CR35","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.ophtha.2006.10.030","volume":"114","author":"YJ Shin","year":"2007","unstructured":"Shin YJ, Park KH, Hwang JM, Wee WR, Lee JH. A new color vision test to differentiate congenital and acquired color vision defects. Ophthalmology. 2007;114(7):1341\u201347. https:\/\/doi.org\/10.1016\/j.ophtha.2006.10.030.","journal-title":"Ophthalmology"},{"issue":"3","key":"4907_CR36","first-page":"233","volume":"1","author":"R Behbehani","year":"2007","unstructured":"Behbehani R. Clinical approach to optic neuropathies. Clin Ophthalmol. 2007;1(3):233\u201346.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"4907_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/col.22155","volume":"43","author":"R Littlewood","year":"2018","unstructured":"Littlewood R, Hyde F. The \u201cC test\u201d for tritan discrimination. Color Res Appl. 2018;43(1):58\u201364. https:\/\/doi.org\/10.1002\/col.22155.","journal-title":"Color Res Appl"},{"key":"4907_CR38","doi-asserted-by":"publisher","first-page":"898064","DOI":"10.3389\/fneur.2022.898064","volume":"13","author":"D Bruegger","year":"2022","unstructured":"Bruegger D, Koth AL, Dysli M, Goldblum D, Abegg M, Tschopp M, et al. Evaluation of the reddesa chart, a new red desaturation testing method, for optic neuritis screening and grading in clinical routine. Front Neurol. 2022;13:898064. https:\/\/doi.org\/10.3389\/fneur.2022.898064.","journal-title":"Front Neurol"},{"issue":"8","key":"4907_CR39","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00417-014-2687-2","volume":"252","author":"Y Almog","year":"2014","unstructured":"Almog Y, Gepstein R, Nemet AY. A simple computer program to quantify red desaturation in patients with optic neuritis. Graefes Arch Clin Exp Ophthalmol. 2014;252(8):1305\u201308. https:\/\/doi.org\/10.1007\/s00417-014-2687-2.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4907_CR40","doi-asserted-by":"crossref","unstructured":"Mollon JD, Astell S, Reffin JP. A minimalist test of colour vision. In Colour vision deficiencies X: Proceedings of the tenth symposium of the international research group on colour vision deficiencies, held in Cagliari, Italy 25\u201328 June 1989, 31 Jul 1991 (pp. 59\u201367). Dordrecht: Springer Netherlands.","DOI":"10.1007\/978-94-011-3774-4_8"},{"issue":"1","key":"4907_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/col.22599","volume":"46","author":"JL Barbur","year":"2021","unstructured":"Barbur JL, Rodriguez-Carmona M, Evans BEW. Color vision assessment-3. An efficient, two-step, color assessment protocol. Color Res Appl. 2021;46(1):33\u201345. https:\/\/doi.org\/10.1002\/col.22599.","journal-title":"Color Res Appl"},{"issue":"5","key":"4907_CR42","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/col.22929","volume":"49","author":"PA Davison","year":"2024","unstructured":"Davison PA, Scanlon G. Comparative analysis of four color vision screening tests benchmarked by anomaloscopy for detection and investigation of protanomaly and deuteranomaly. Color Res Appl. 2024;49(5):474\u201385. https:\/\/doi.org\/10.1002\/col.22929.","journal-title":"Color Res Appl"},{"key":"4907_CR43","doi-asserted-by":"publisher","DOI":"10.4324\/9781003397182","volume-title":"Colour, colour measurement and colour change","author":"D Saunders","year":"2024","unstructured":"Saunders D. Colour, colour measurement and colour change. London: Taylor & Francis; 2024."},{"key":"4907_CR44","first-page":"3","volume-title":"Color vision: from genes to perception","author":"LT Sharpe","year":"1999","unstructured":"Sharpe LT, Stockman A, Jagle H, Nathans J. Opsin genes, cone photopigments, color vision, and color blindness. In: Gegenfurtner KR, Sharpe LT, editors. Color vision: from genes to perception. Cambridge: Cambridge University Press; 1999. p. 3\u201351."},{"issue":"1","key":"4907_CR45","first-page":"24","volume":"39","author":"K Green","year":"2007","unstructured":"Green K. Acquired colour vision assessment - is Ishihara really enough? Aust Orthopt J. 2007;39(1):24\u201330.","journal-title":"Aust Orthopt J"},{"key":"4907_CR46","doi-asserted-by":"publisher","first-page":"661938","DOI":"10.3389\/fneur.2021.661938","volume":"12","author":"US Kim","year":"2021","unstructured":"Kim US, Mahroo OA, Mollon JD, Yu-Wai-Man P. Retinal ganglion cells\u2014diversity of cell types and clinical relevance. Front Neurol. 2021;12:661938. https:\/\/doi.org\/10.3389\/fneur.2021.661938.","journal-title":"Front Neurol"},{"issue":"5","key":"4907_CR47","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1046\/j.1460-9568.2000.00041.x","volume":"12","author":"A Hanazawa","year":"2000","unstructured":"Hanazawa A, Komatsu H, Murakami I. Neural selectivity for hue and saturation of colour in the primary visual cortex of the monkey. Eur J Neurosci. 2000;12(5):1753\u201363. https:\/\/doi.org\/10.1046\/j.1460-9568.2000.00041.x.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"4907_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-vision-121219-081801","volume":"6","author":"GD Horwitz","year":"2020","unstructured":"Horwitz GD. Signals related to color in the early visual cortex. Annu Rev Vis Sci. 2020;6(1):287\u2013311. https:\/\/doi.org\/10.1146\/annurev-vision-121219-081801.","journal-title":"Annu Rev Vis Sci"},{"issue":"7","key":"4907_CR49","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.visres.2011.02.012","volume":"51","author":"R Shapley","year":"2011","unstructured":"Shapley R, Hawken MJ. Color in the cortex: single- and double-opponent cells. Vision Res. 2011;51(7):701\u201317. https:\/\/doi.org\/10.1016\/j.visres.2011.02.012.","journal-title":"Vision Res"},{"issue":"6","key":"4907_CR50","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/eye.2016.298","volume":"31","author":"IH Yusuf","year":"2017","unstructured":"Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye. 2017;31(6):828\u201345. https:\/\/doi.org\/10.1038\/eye.2016.298.","journal-title":"Eye"},{"issue":"6","key":"4907_CR51","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TYY, Melles RB, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123(6):1386\u201394. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.058.","journal-title":"Ophthalmology"},{"key":"4907_CR52","doi-asserted-by":"publisher","unstructured":"Ageed A, Aslam MD, El Haouari S. Acquired dyschromatopsia and its link to drug toxicity. Cureus. 2024;16(12):e76190. https:\/\/doi.org\/10.7759\/cureus.76190.","DOI":"10.7759\/cureus.76190"},{"key":"4907_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/B978-0-323-34044-1.00002-X","volume-title":"Liu, Volpe, and Galetta\u2019s neuro-ophthalmology","author":"GT Liu","year":"2019","unstructured":"Liu GT, Volpe NJ, Galetta SL. The neuro-ophthalmic examination. In: Liu GT, Volpe NJ, Galetta SL, editors. Liu, Volpe, and Galetta\u2019s neuro-ophthalmology. 3rd ed. Elsevier; 2019. p. 7\u201336.","edition":"Third"},{"key":"4907_CR54","doi-asserted-by":"publisher","first-page":"945034","DOI":"10.3389\/fneur.2022.945034","volume":"13","author":"MNL Nguyen","year":"2022","unstructured":"Nguyen MNL, Zhu C, Kolbe SC, Butzkueven H, White OB, Fielding J, et al. Early predictors of visual and axonal outcomes after acute optic neuritis. Front Neurol. 2022;13:945034. https:\/\/doi.org\/10.3389\/fneur.2022.945034.","journal-title":"Front Neurol"},{"issue":"2","key":"4907_CR55","first-page":"7","volume":"40","author":"A French","year":"2008","unstructured":"French A, Rose K, Cornell E, Thompson K. The evolution of colour vision testing. Aust Orthopt J. 2008;40(2):7\u201315.","journal-title":"Aust Orthopt J"},{"issue":"1","key":"4907_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3357\/ASEM.3111.2012","volume":"83","author":"M Rodriguez-Carmona","year":"2012","unstructured":"Rodriguez-Carmona M, O\u2019Neill-Biba M, Barbur JL. Assessing the severity of color vision loss with implications for aviation and other occupational environments. Aviat Space Environ Med. 2012;83(1):19\u201329. https:\/\/doi.org\/10.3357\/ASEM.3111.2012.","journal-title":"Aviat Space Environ Med"},{"key":"4907_CR57","doi-asserted-by":"publisher","unstructured":"Fernandes TP, Santos NA, Paramei GV. Cambridge colour test: reproducibility in normal trichromats. J Opt Soc Am A. 2020;37(4):A70\u2013A80 https:\/\/doi.org\/10.1364\/JOSAA.380306.","DOI":"10.1364\/JOSAA.380306"},{"key":"4907_CR58","doi-asserted-by":"publisher","unstructured":"Paramei GV, Oakley B. Variation of color discrimination across the life span. J Opt Soc Am A. 2014;31(4)A375\u2013A84. https:\/\/doi.org\/10.1364\/JOSAA.31.00A375.","DOI":"10.1364\/JOSAA.31.00A375"},{"issue":"3","key":"4907_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/vision8030053","volume":"8","author":"R Truksa","year":"2024","unstructured":"Truksa R, Fomins S, Jansone-Langina Z, Tenisa L. Colour vision changes across lifespan: insights from FM100 and CAD tests. Vision (Basel). 2024;8(3):53. https:\/\/doi.org\/10.3390\/vision8030053.","journal-title":"Vision (Basel)"},{"issue":"5","key":"4907_CR60","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0002-9394(14)77380-5","volume":"93","author":"G Verriest","year":"1982","unstructured":"Verriest G, Laethem JV, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores. Am J Ophthalmol. 1982;93(5):635\u201342. https:\/\/doi.org\/10.1016\/S0002-9394(14)77380-5.","journal-title":"Am J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04907-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04907-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04907-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:27:43Z","timestamp":1783405663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04907-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4907"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04907-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This diagnostic study received ethics approval from the Royal Victorian Eye and Ear Hospital Human Research Ethics Committee for data collection at the Essendon Eye Clinic. Recruited individuals were provided verbal and written explanations of the research and their role. Prior to voluntary participation, all enrolled subjects gave written informed consent. This research adhered to the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}